Internal Medicine, Endocrinology, Diabetes, & Metabolism · Beaumont, TX
NPI
1053321539
Since 2006
Specialty
Internal Medicine, Endocrinology, Diabetes, & Metabolism
Code 207RE0101X
Group practices
2
Medicare group memberships
Hospitals
3
Hospital affiliations
3030 North St, Suite 560
Beaumont, TX, 77702
Phone (409) 835-9834
Groups this clinician bills Medicare through
Medicare paid, 2024
$1.3M
95,580 services
Medicare patients, 2024
767
Average age 74
Drug cost, 2024
$1.4M
3,576 prescriptions
Company payments, 2025
$140K
From 25 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Robert C Hood was code J3111 (injection, romosozumab-aqqg, 1 mg), 43,890 times for 41 patients. In total Robert C Hood billed 95,580 services in 49 codes, and Medicare paid $1.3M.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2010-07-07.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| J3111 Injection, romosozumab-aqqg, 1 mg | Office | 43,890 | 41 | $8.35 | $367K |
| J0897 Injection, denosumab, 1 mg | Office | 26,880 | 253 | $20.28 | $545K |
| J1306 Injection, inclisiran, 1 mg | Office | 7,100 | 14 | $9.52 | $68K |
| 36415 Venipuncture Blood Collection | Office | 1,788 | 641 | $8.64 | $15K |
| 83036 Blood Count | Office | 1,334 | 477 | $9.48 | $13K |
| 84520 Clinical Chemistry | Office | 1,264 | 558 | $3.86 | $4,878 |
| 84132 Clinical Chemistry | Office | 1,143 | 546 | $4.64 | $5,305 |
| 82310 Clinical Chemistry | Office | 1,139 | 523 | $5.05 | $5,750 |
| 82565 Clinical Chemistry | Office | 1,118 | 543 | $5.00 | $5,594 |
| 80076 Clinical Chemistry | Office | 1,059 | 517 | $7.99 | $8,461 |
| 82947 Clinical Chemistry | Office | 1,044 | 467 | $3.82 | $3,990 |
| 80061 Clinical Chemistry | Office | 1,021 | 479 | $13.10 | $13K |
| 99214 Office E&M - Established | Office | 863 | 497 | $76.73 | $66K |
| 84443 Clinical Chemistry | Office | 724 | 491 | $16.40 | $12K |
| 96372 Injection Administration | Office | 652 | 285 | $9.18 | $5,986 |
By year: 2022 $1.0M for 67,024 services; 2023 $1.2M for 87,368 services; 2024 $1.3M for 95,580 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 36415 Venipuncture Blood Collection | 1,788 | 641 | $8.64 | $15K |
| 83036 Blood Count | 1,334 | 477 | $9.48 | $13K |
| 84520 Clinical Chemistry | 1,264 | 558 | $3.86 | $4,878 |
| 84132 Clinical Chemistry | 1,143 | 546 | $4.64 | $5,305 |
| 82310 Clinical Chemistry | 1,139 | 523 | $5.05 | $5,750 |
| 82565 Clinical Chemistry | 1,118 | 543 | $5.00 | $5,594 |
| 80076 Clinical Chemistry | 1,059 | 517 | $7.99 | $8,461 |
| 82947 Clinical Chemistry | 1,044 | 467 | $3.82 | $3,990 |
| 80061 Clinical Chemistry | 1,021 | 479 | $13.10 | $13K |
| 84443 Clinical Chemistry | 724 | 491 | $16.40 | $12K |
Medicare prescription drug claims, 2024
In 2024, the drug Robert C Hood prescribed most often to Medicare patients was Synthroid (Levothyroxine Sodium), with 353 prescriptions and refills. In total Robert C Hood wrote 3,576 Medicare prescriptions that cost $1.4M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Synthroid Levothyroxine Sodium | 353 | 721 | 97 | $31K |
| Pioglitazone Hcl Generic | 327 | 874 | 124 | $4,590 |
| Ozempic Semaglutide | 215 | 342 | 54 | $320K |
| Rosuvastatin Calcium Generic | 191 | 482 | 69 | $2,421 |
| Ezetimibe Generic | 186 | 445 | 61 | $4,043 |
| Atorvastatin Calcium Generic | 165 | 458 | 59 | $1,449 |
| Mounjaro Tirzepatide | 150 | 241 | 40 | $248K |
| Jardiance Empagliflozin | 140 | 247 | 38 | $139K |
| Metformin Hcl Generic | 122 | 340 | 50 | $1,235 |
| Metformin Hcl Er Metformin Hcl | 106 | 262 | 36 | $1,276 |
| Carvedilol Generic | 85 | 201 | 27 | $981 |
| Unithroid Levothyroxine Sodium | 75 | 188 | 28 | $3,920 |
| Tresiba Flextouch U-200 Insulin Degludec | 72 | 157 | 36 | $94K |
| Levoxyl Levothyroxine Sodium | 71 | 200 | 27 | $2,518 |
| Losartan Potassium Generic | 66 | 186 | 28 | $778 |
Brand drugs: 1,598 claims; generic drugs: 1,885 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Robert C Hood $140K ($140K in general payments such as food, travel and fees) from 25 companies. The largest payer was Novo Nordisk Inc with $63K.
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc NVO | 48 | $63K |
| Amgen Inc. AMGN | 80 | $58K |
| Lilly USA, LLC LLY | 22 | $13K |
| Medtronic, Inc. MDT | 16 | $4,355 |
| Abbvie Inc. ABBV | 17 | $302 |
| Novartis Pharmaceuticals Corporation NVS | 13 | $142 |
| Dexcom, Inc. DXCM | 11 | $137 |
| Corcept Therapeutics CORT | 5 | $101 |
| Madrigal Pharmaceuticals MDGL | 3 | $87.25 |
| Mannkind Corporation MNKD | 3 | $82.12 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.